lupin logo.jpg
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®
09. Februar 2022 07:23 ET | Lupin Ltd
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla® Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic...